Cell Therapy News Volume 26.13 | Jul 28 2025

    0
    46








    2025-07-28 | CTN 26.13


    Cell Therapy News by STEMCELL Technologies
    Vol. 26.13 – 28 July, 2025
    TOP STORY

    Donor-Derived CD7 CAR T Cells for Pediatric and Adult Relapsed/Refractory T-ALL/LBL: A Phase II Trial

    This Phase II trial assessed CD7 CAR T-cells derived from previous transplant or newly HLA-matched donors for relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma.
    [Blood]

    Abstract
    PUBLICATIONSListed by the impact factor of the journal

    CAR-Engineered Lymphocyte Persistence Is Governed by a FAS Ligand-FAS Autoregulatory Circuit

    Scientists constructed a single-cell atlas of diverse cancers to identify cellular subsets expressing FASLG, the gene encoding FAS-ligand.
    [Nature Cancer]

    Full Article

    Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation

    A 3D micrometastases model was developed to mimic key microenvironmental cues, enabling in vitro evaluation of CAR T cell immunotherapy.
    [Advanced Science]

    Full Article

    Chimeric Antigen Receptor T Cells in Treatment-Refractory DAGLA Antibody-Associated Encephalitis

    Investigators successfully treated a 36-year-old patient with severe autoimmune encephalitis using CAR T cells.
    [Med]

    Full ArticleGraphical Abstract

    Recreating Pathophysiology of CLN2 Disease and Demonstrating Reversion by TPP1 Gene Therapy in hiPSC-Derived Retinal Organoids and Retina-on-Chip

    Leveraging hiPSC-derived retinal organoids, retinal pigmented epithelial cells, and the retina-on-chip system, scientists established an in vitro neuronal ceroid lipofuscinosis type 2 (CLN2) model that recreates the principal histological hallmarks.
    [Cell Reports Medicine]

    Full ArticleGraphical Abstract

    Tumor-Targeted Cytokine Delivery by Engineered Myeloid Cells Unlocks CAR T Cell Efficacy and Endogenous T Cell Responses in Glioblastoma

    Researchers reported a gene therapy strategy to reprogram the tumor microenvironment and revive the therapeutic potential of CAR T cells by leveraging tumor-infiltrating macrophages as vehicles for tumor-targeted gene-based delivery of immune-activating cytokines.
    [Molecular Therapy]

    AbstractGraphical Abstract

    The Pronounced Cytotoxic Effects of Chimeric Antigen Receptor T Cells Targeting B7-H3 in Organoids and Liver Xenografts Derived from Colorectal Cancer Patients

    By analyzing the expression of B7-H3 in colorectal cancer (CRC) tissue and cell lines using immunohistochemistry and flow cytometry, respectively, the authors identified B7-H3 as a potential target in CRC.
    [British Journal of Cancer]

    Full ArticleGraphical Abstract

    hCCL19-Expressing Recombinant Newcastle Disease Virus Boosts CAR T Cell Infiltration and Efficacy in Solid Tumor

    Investigators constructed a recombinant Newcastle disease virus expressing human CCL19 and evaluated its therapeutic efficacy alongside doxycycline-inducible CAR T cells in an orthotopic lung cancer mouse model.
    [Journal of Immunotherapy of Cancer]

    Full Article

    AAV9-Mediated Transduction of Memory Circuits following Convection-Enhanced Delivery into the Olfactory Bulbs

    Using convection-enhanced delivery of AAV9 encoding green fluorescent protein, scientists mapped the extensive neural connectivity from the olfactory bulb to key memory-related brain regions.
    [Gene Therapy]

    Full Article
    An image of a STEMCELL-branded box with three vials of ImmunoCult™️ reagents for the activation and expansion of mouse T cells
    REVIEWS

    Osteoarthritis Gene Therapy: Expanding the Scope of Genetic Therapies

    Gene therapy has traditionally targeted rare Mendelian disorders and cancer. However, gene transfer may also be harnessed to treat common, complex diseases, delivering therapeutic cDNAs into patients who are genetically unremarkable.
    [Molecular Therapy]

    Abstract

    Discordant CAR-T Cell Signaling: Implications of Divergence from Physiological T Cell Activation

    By comparing the mechanisms of lymphocyte activation by CARs vs. T cell receptors, scientists discuss how these chimeric constructs induce a stimulation characterized by un-orchestrated, incomplete, or impaired signaling events that in turn could explain some of their shortcomings.
    [Journal of Translational Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore

    Elpis Biopharmaceuticals announced the signing of a Memorandum of Understanding with the National Cancer Centre Singapore. The partnership will support collaborative cell therapy research and clinical trials for the treatment of a variety of cancers.
    [Elpis Biopharmaceuticals (PR Newswire)]

    Press Release
    FEATURED EVENT

    Francis Crick Symposium in Neuroscience: Development, Plasticity, and Function of Neural Circuits

    September 8-12, 2025
    Suzhou, China

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – Gene Therapy of Preleukemia Syndromes

    Universitätsklinikum Tübingen – Tübingen, Germany

    Postdoctoral Research Fellow – Leukemogenesis and Leukemia

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Research Fellow – Leukemia and Epigenetics

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Full Professor – Neuroimmunology

    Salk Institute for Biological Studies – La Jolla, California, United States

    Associate Professor or Professor – Surgery

    University of British Columbia Department of Surgery – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2